rindock docket 94n0374 rindock doctitl drug export gemzar reg gemcitabin hydrochlorid bulk drug glass vial 200 mg 1 g free base per vial doctitl agenc agenc food drug administr hh agenc action action notic action summari summari food drug administr fda announc lilli research laboratori divis eli lilli co file applic request condit approv export human drug gemzar reg gemcitabin hydrochlorid bulk drug glass vial 200 mg 1 g free base per vial franc summari address address relev inform applic may direct docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 contact person identifi futur inquiri concern export human drug drug export amend act 1986 also direct contact person address inform contact jame e hamilton center drug evalu research hfd313 food drug administr 5600 fisher lane rockvil md 20857 3015942073 supplem supplementari inform drug export provis section 802 feder food drug cosmet act act 21 u c 382 provid fda may approv applic export drug current approv unit state section 802 b 3 b act set forth requir must met applic approv section 802 b 3 c act requir agenc review applic within 30 day file determin whether requir section 802 b 3 b satisfi section 802 b 3 act requir agenc publish notic feder regist within 10 day file applic export facilit public particip review applic meet requir agenc provid notic lilli research laboratori divis eli lilli co lilli corpor center indianapoli 46285 file applic request condit approv export human drug gemzar reg gemcitabin hydrochlorid bulk drug glass vial 200 mg 1 g free base per vial franc gemzar reg indic treatment patient local advanc metastat nonsmal cell lung cancer applic receiv file center drug evalu research august 18 1994 shall consid file date purpos act interest person may submit relev inform applic docket manag branch address two copi except individu may submit singl copi identifi docket number found bracket head document submiss may seen docket manag branch 9 4 p monday friday agenc encourag person submit relev inform applic octob 31 1994 provid addit copi submiss directli contact person identifi facilit consider inform 30 day review period notic issu feder food drug cosmet act sec 802 21 u c 382 author deleg commission food drug 21 cfr 5 10 redeleg center drug evalu research 21 cfr 5 44 date septemb 29 1994 supplem signer david b barr signer signjob deputi director offic complianc center drug evalu research signjob frfile fr doc 9426077 file 102094 8 45 frfile bill bill code 416001f bill